Abstract
We used an ultrasound-enhanced scintillation proximity assay to accurately determine the levels of complement decay-accelerating factor (CD55) for the early detection and assessment of the progression of pleural metastatic lung cancer. We found that the expression of CD55 in metastatic tumor tissues is 2.8 times higher than that in the serum at the early stages. We also found that the concentration of CD55 in serum decreases with the progression of metastasis. These results suggest that CD55 is a potential biomarker for the prediction of pleural metastatic lung cancer.
Similar content being viewed by others
References
Agalioti T, Giannou AD (2015) Stathopoulos GT. Pleural involvement in lung cancer. J Thorac Dis 7(6):1021–1030
Psallidas I, Kalomenidis I, Porcel JM, Robinson BW (2016) Stathopoulos GT. Malignant pleural effusion: from bench to bedside. Eur Respir Rev 25:189–198
Zhu K, Chen L, He C, Lang Y, Kong X, Qu C, Xu S (2020) Prediction of pleural invasion in challenging non-small-cell lung cancer patients using serum and imaging markers. Dis Markers. https://doi.org/10.1155/2020/6430459
Morgensztern D, Waqar S, Subramanian J, Trinkaus K, Govindan R (2012) Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer. J Thorac Dis 7:1485–1489
Huang H, Wang T, Hu B, Pan C (2015) Visceral pleural invasion remains a size-independent prognostic factor in stage I non-small cell lung cancer. Ann Thorac Surg 99(4):1130–1139
Dho SH, Kim SY, Chung C, Cho EH, Lee SY, Kim JY, Kim LK, Min SW, Lee J, Jung SH, Lim JC (2017) Development of a radionuclide-labeled monoclonal anti-CD55 antibody with theranostic potential in pleural metastatic lung cancer. Sci Rep 8:8960–8972
Dho SH, Lim JC, Kim LK (2018) Beyond the role of CD55 as a complement component. Immune Netw 18(1):e11
Mikesch JH, Schier K, Roetger A, Simon R, Buerger H, Brandt B (2006) The expression and action of decay-accelerating factor (CD55) in human malignancies and cancer therapy. Cell Oncol 28:223–232
Ikeda JI, Morii E, Liu Y, Qiu Y, Nakamichi N, Jokoji R, Miyoshi Y, Noguchi S, Aozasa K (2008) Prognostic significance of CD55 expression in breast cancer. Clin Cancer Res 14:4780–4786
Durrant LG, Chapman MA, Buckley DJ, Spendlove I, Robins RA, Armitage NC (2006) Enhanced expression of the complement regulatory protein CD55 predicts a poor prognosis in colorectal cancer patients. Cancer Immunol Immunother 52:638–642
Vadrevu SK, Chintala NK, Sharma SK, Sharma P, Cleveland C, Riediger L (2014) Complement C5a receptor facilitates cancer metastasis by altering T-cell responses in the metastatic niche. Cancer Res 74(13):3454–3465
Scicchitano MS, Dalmas DA, Boyce RW, Thomas HC, Frazier KS (2009) Protein extraction of formalin-fixed, paraffin-embedded tissue enables robust proteomic profiles by mass spectrometry. J Histochem Cytochem 57:849–860
Shi SR, Liu C, Balgley BM, Lee C, Taylor CR (2006) Protein extraction from formalin-fixed, paraffin-embedded tissue sections: quality evaluation by mass spectrometry. J Histochem Cytochem 54:739–743
Lee SY, Lim JC, Cho EH, Jung SH (2016) A new scintillation proximity assay-based approach for the detection of KRAS mutations. Radiochim Acta 104:59–65
Lee SY, Lim JC, Cho EH, Lee SK, Jung SH (2019) Ultrasound-enhanced scintillation proximity assay for rapid diagnostics. Anal Biochem 570:51–55
Yang S, Yang L, Teng L, Zhang S, Cui Y, Cao Y, Shi H (2018) Visceral pleural invasion by pulmonary adenocarcinoma ≤ 3 cm: the pathological correlation with pleural signs on computed tomography. J Thorac Dis 10(7):3992–3999
Acknowledgements
This work was supported by Korea Atomic Energy Research Institute: Development of Radioisotope Production and Application Technology [524430-20].
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Lee, SY., Lim, JC., Cho, EH. et al. Predicting pleural metastasis by detecting CD55 using an ultrasound-enhanced scintillation proximity assay. J Radioanal Nucl Chem 327, 707–712 (2021). https://doi.org/10.1007/s10967-020-07559-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10967-020-07559-x